Medgenics Receives Notice of Allowance from the U.S. Patent Office for Claims That Expand IP for Its Platform Technology to Additional Therapeutic Proteins

[Business Wire] – Medgenics, Inc. , the developer of Biopumpâ„¢, a novel technology for the sustained production and delivery of therapeutic protei more

View todays social media effects on MDGN

View the latest stocks trending across Twitter. Click to view dashboard

See who Medgenics is hiring next, click here to view